All

Ferring Pharmaceuticals and PharmaBiome announced a research & development collaboration to drive forward new microbiome-based biotherapeutics in the field of gastroenterology. The deal provides Ferring…

TOLREMO today announced that the first patient has been dosed in its first-in-human clinical trial evaluating the safety and tolerability, pharmacokinetics, and pharmacodynamics of its…

Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma.  Boehringer Ingelheim today announced the acquisition of privately-held T3 Pharma…

Versameb AG, a leading pre-clinical stage biotechnology company, has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND)…

This first-in-human study evaluates the safety, tolerability and efficacy of ALE.C04 as a monotherapy and in combination.Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company within our portfolio…

Dr. Markus Kalousek takes on the role of Chairperson at FimmCyte, a pioneering women's health biotech, starting from 1 Nov 2023. With over 25 years in…

Onena Medicines closes 3.7M CHF funding round to advance its novel DSIP targeting antibody portfolio.Onena Medicines AG, a cellular reprogramming platform drug discovery company, announced…

We are delighted to announce that Johnson and Johnson is continuing its partnership with BaseLaunch to help support cutting-edge early-stage biotechs to achieve financing and…

Insights into Roche's partnering and venture fund strategies In our biotech networking event with Roche, powered by Innosuisse, we explored the path from pioneering scientific…